Tendon Disease Trigger Found: HIF1 Protein Linked to Pain & Damage

A team of researchers has identified a key molecular driver behind common tendon problems like Achilles pain, tennis elbow, and jumper’s knee, offering a potential new avenue for treatment development. The discovery, stemming from work at ETH Zurich and Balgrist University Hospital in Zurich, centers on the HIF1 protein and its role in triggering damaging changes within tendons.

These conditions – known collectively as tendinopathies – affect a wide range of people, from young athletes experiencing overuse injuries to older individuals whose tendons have gradually deteriorated. While physiotherapy can provide relief, many cases prove resistant to conventional treatment, highlighting the demand for a deeper understanding of the underlying mechanisms driving these painful conditions. The research, published in Science Translational Medicine, suggests that early intervention may be crucial to preventing irreversible damage.

The Tendon’s Vulnerability: A Matter of Overload and More

Tendons, the fibrous cords that connect muscles to bones, are remarkably strong but inherently vulnerable to overuse. As Professor Jess Snedeker of ETH Zurich explains, tendons “must withstand powerful loads, with all the forces of our muscles being concentrated to the relatively thin tendons that transmit these forces into movement of our skeleton.” This constant strain makes them susceptible to injury, particularly when loads exceed their capacity for repair. Tendinopathies are among the most frequently seen conditions by orthopedic specialists, yet effective treatment options remain limited.

HIF1: From Known Presence to Central Trigger

Researchers have long known that the HIF1 protein levels are elevated in diseased tendons, but its precise role remained unclear. Was the increase simply a consequence of the damage, or was HIF1 actively contributing to the problem? The team, led by Snedeker and Professor Katrien De Bock, set out to answer this question through a series of experiments involving mice and human tendon tissue. Their findings strongly suggest that HIF1 is not merely a bystander, but a central molecular driver of tendon disease.

Experiments with mice revealed a striking correlation between HIF1 activity and tendon health. Mice with permanently activated HIF1 developed tendon disease even without being subjected to overloading, while mice with deactivated HIF1 remained healthy even under stress. These results, combined with analysis of human tendon cells obtained during surgeries, pointed to a specific mechanism: elevated HIF1 levels lead to a pathogenic remodeling of the tendon structure.

How HIF1 Damages Tendons: A Change in Collagen and Nerve Growth

Specifically, the researchers found that increased HIF1 activity promotes the formation of more crosslinks within the collagen fibers that form the foundation of tendons. “This makes the tendons more brittle and impairs their mechanical function,” explains Greta Moschini, a doctoral student and lead author of the study. They observed increased growth of blood vessels and nerves into the tendon tissue, which could explain the pain commonly associated with tendinopathy. This nerve growth is a particularly interesting finding, as it suggests a potential link between inflammation, structural changes, and the experience of pain.

Implications for Athletes and Beyond

The study’s findings have significant implications, particularly for young athletes who frequently experience tendinopathies. Snedeker emphasizes the importance of early treatment, noting that damage caused by HIF1 can accumulate over time and develop into irreversible. “Physiotherapy then no longer helps, and the only treatment at this moment is to surgically remove the diseased tendon,” he states. This underscores the need for proactive management of tendon health and early intervention when symptoms arise.

Beyond HIF1: The Challenge of Targeted Therapies

While identifying HIF1 as a key driver is a major step forward, developing effective treatments is not straightforward. HIF1 plays a crucial role in many bodily functions, including responding to low oxygen levels (hypoxia). Completely shutting down HIF1 throughout the body could lead to unintended and potentially harmful side effects, as Professor De Bock points out. “Switching HIF1 off throughout the body would likely lead to side effects.”

Researchers are now exploring more targeted approaches, such as finding ways to deactivate HIF1 specifically within tendon tissue. Alternatively, they are investigating the biochemical processes surrounding HIF1 to identify other molecules that could serve as more suitable targets for therapeutic intervention. This involves a detailed examination of how HIF1 influences gene activity within tendon cells, with the goal of pinpointing specific pathways that contribute to disease development. Futurity.org reports on this research, highlighting the potential for future treatments.

What’s Next: Refining Targets and Exploring New Avenues

The research team is now focused on unraveling the complex biochemical interactions surrounding HIF1 within tendon cells. This detailed investigation aims to identify additional molecules influenced by HIF1 that could be more amenable to targeted therapies. Further studies will be needed to validate these findings and translate them into clinical applications. The process of developing new treatments is often lengthy and complex, involving preclinical studies, clinical trials, and regulatory review. Although, this discovery provides a promising new direction for addressing the challenges of tendinopathies and improving the lives of those affected by these debilitating conditions. ScienceDaily as well covers this breakthrough, emphasizing the potential for new treatment strategies.

For individuals experiencing tendon pain, consulting with a qualified healthcare professional is essential for accurate diagnosis and appropriate management. Staying informed about the latest research and following evidence-based recommendations can help optimize outcomes and prevent long-term complications. SciTechDaily provides additional details on the study’s findings and their potential impact.